The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index; 1 of the 21 sources its claims cite were checked for support.
Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice
Open accessAbstract
The accumulation of beta-amyloid (A beta) plaques and neurofibrillary tangles consisting of hyperphosphorylated tau protein are pathological features of Alzheimer's disease (AD) commonly modeled in mice using known human familial mutations; however, the loss of neurons also found to occur in AD is rarely observed in such models. The mechanism of neuron degeneration remains unclear but is of great interest as it is very likely an important factor for the onset of adverse memory deficits occurring in individuals with AD. The role of A beta in the neuronal degeneration is a matter of controversial debates. In the present study we investigated the impact of extracellular plaque A beta versus intraneuronal A beta on neuronal cell death. The thalamus and the frontal cortex of the APP/PS1KI mouse model were chosen for stereological quantification representing regions with plaques only (thalamus) or plaques as well as intraneuronal A beta (frontal cortex). A loss of neurons was found in the frontal cortex at the age of 6 months coinciding with the decrease of intraneuronal immunoreactivity, suggesting that the neurons with early intraneuronal A beta accumulation were lost. Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex. This study suggests that plaques have no effect on neuron death whereas accumulation of intraneuronal A beta may be an early transient pathological event leading to neuron loss in AD.
Overview
CoChat Summary
TL;DR
In APP/PS1KI mice, frontal cortex showed transient intraneuronal Aβ accumulation and neuron loss, whereas thalamus had comparable plaque pathology but no intraneuronal Aβ and no neuron loss. The authors conclude that plaques do not affect neuronal survival, while transient intraneuronal Aβ accumulation coincides with neuron death.
Key findings
- Frontal cortex neuron loss was 28% at 6 months and 35% at 12 months in APP/PS1KI mice versus PS1KI controls, with corresponding cortical volume reductions of 25% and 23% at 6 and 12 months.
- Thalamus showed no significant neuron loss at 2, 6, or 12 months despite plaque pathology; Aβ-covered area was 1.5% at 2 months, 8.5% at 6 months, and 13.9% at 12 months, with the increase due to an 11-fold rise in plaque number from 2 to 12 months and no major change in average plaque size.
- Frontal cortex Aβ-covered area was 4.7% at 2 months and 12.1% at 6 months, then remained stable to 12 months; intraneuronal Aβ was prominent at 1.5 and 2 months and decreased at 6 months, while the 2-to-6-month increase in Aβ area was due to a 2.7-fold increase in grain numbers.
- No intraneuronal Aβ was detected in thalamus regardless of age; APP transgene expression was found in frontal cortex neurons but not thalamic neurons.
Methods
- APP/PS1KI mice and PS1KI controls were analyzed; stereology used female mice at 2 months (n = 5), 6 months (n = 6), and 12 months (n = 8). Aβ load quantification used 3, 5, and 4 animals at 2, 6, and 12 months, respectively.
- Design-based stereology (optical fractionator) was performed on cresyl violet-stained frozen sections, counting every tenth section, with frontal cortex quantified from Bregma 3.08–0.26 and thalamus from Bregma −0.94 to −2.54; counting was blinded to genotype.
- Immunohistochemistry used 4G8, an N-terminal Aβ antibody, N1D, N3pE, and G2-10; Aβ load was measured with ImageJ. Stereology data were analyzed by two-way ANOVA with Bonferroni posttests, and Aβ pathology by one-way ANOVA followed by t tests.
Limitations
- The paper states that it cannot completely rule out that thalamic neurons differ from cortical neurons and may be less vulnerable in general.
- The paper states that mutant PS1 may induce toxic effects per se, but because PS1KI littermate controls had unchanged neuron numbers, the authors conclude the PS1-FAD mutations alone had no effect on neuron survival.
- Evident from the text: the findings are correlational in a mouse model, only female mice were analyzed, and the authors note that proving the intraneuronal Aβ hypothesis in human AD tissue is difficult because end-stage pathology may no longer show intraneuronal Aβ immunoreactivity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 6 Not checked · 22 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A loss of neurons was found in the frontal cortex at the age of 6 months coinciding with the decrease of intraneuronal immunoreactivity”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Correspondingly, no change in thalamic volume was found between APP/PS1KI and PS1KI control mice at any age investigated”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“as we have used PS1KI littermates as control mice, which have unchanged neuron numbers during aging in both thalamus and frontal cortex”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
10 more claims
Create a free account to see all 30 claims and to verify the 20 references still open.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“PS1/APP mutant transgenic mice were shown to have prominent intraneuronal Aβ accumulation associated with neuron cell death [23, 35, 167].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“While the frontal cortex represents an area with both intra- and extracellular Aβ accumulation, no intracellular deposits are present in the thalamus. The amount of extracellular plaque pathology, however, is comparable between both brain regions, pointing to a critical role of transient intraneuronal Aβ accumulations with regard to neurodegeneration [53].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 6
“an increased number of deposits ( c ) as no change in average deposit size was detected ( e ).”
§ Results · p. 6
“the average size decreased ( c ) and the number of deposits tended to increase ( e , P = 0.075).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 6
“no change in thalamic volume was found between APP/PS1KI and PS1KI control mice at any age investigated (Fig. 5d).”
§ Discussion · p. 7
“otherwise no changes in thalamic volume were observed ( e ).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“increases further to 13.9% in the thalamus (Fig. 4a, b).”
§ Discussion · p. 7
“extracellular plaques covering 13.1% of this region at the age of 12 months.”
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundThe Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 1×
“Estimation of the total number of neurons in hemispheres was performed according to the principle of stereology [17, 21, 24].”
MethodAlzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundDifferences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 2×
“The APP/PS1KI mice represent a valuable model system, as they develop an extensive neuron loss in the CA1 region of the hippocampal formation [4], a characteristic also found in AD patients [22], which is preceded by strong intraneuronal Ab accumulation, as well as a severe motor pathology, axonal degeneration marked…”
BackgroundIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 2×
“In addition, another study claims that intraneuronal Ab42 in human AD is only detectable in patients with low Braak stages and short disease duration and that the intraneuronal immunoreactivity is lost in patients with more progressive AD [11].”
BackgroundDesign-based stereology in neuroscience
Schmitz, C., & Hof, P. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.050 · Cited by 681 · cited 1×
“Estimation of the total number of neurons in hemispheres was performed according to the principle of stereology [17, 21, 24].”
MethodFibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · cited 1×
“Plaques are known to cause disturbances in the fiber network developing dystrophic swellings of surrounding fibers and mediate loss of dendritic spines [1, 7, 19, 29].”
BackgroundCasas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400 · cited 2×
“The APP/PS1KI mice represent a valuable model system, as they develop an extensive neuron loss in the CA1 region of the hippocampal formation [4], a characteristic also found in AD patients [22], which is preceded by strong intraneuronal Ab accumulation, as well as a severe motor pathology, axonal degeneration marked…”
BackgroundMethodSelf-citation
Cited by
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
“They concluded that the neuronal loss was related to iAb [66].”
BackgroundJawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.027 · Cited by 623
“…striatum, representing regions where only extracellular plaques are detectable, no neuron loss could be demonstrated (Breyhan et al., 2009; Casas et al., 2004; Christensen et al., 2008; Christensen et al., 2010), arguing against a significant role of extracellular plaques in terms of A toxicity.”
BackgroundMethodInfluentialSelf-citationYang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429
“…accumulation of intraneuronal Ab in Alzheimer’s disease is an early event that precedes extracellular Ab deposition (Takahashi et al., 2002; Cataldo et al., 2004a; Billings et al., 2005) and is strongly implicated in the mechanism of neurodegeneration in these models (Christensen et al., 2008).”
BackgroundEimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425
“The early appearance of intraneuronal Aβ42 and its correlation with neuron loss in 5XFAD mice is also shared with the APPPS1KI transgenic mouse model [11,33,37,38].”
BackgroundIntraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
“Additionally, PS1/APP mutant transgenic mice were shown to have prominent intraneuronal Ab accumulation associated with neuron cell death [23, 35, 167].”
Metadata
- Authors
- Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M.-C., Wirths, O., & Bayer, T. A.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Wirths, Oliver
- Venue
- Acta Neuropathologica
- Published
- 2008-10-31
- Volume
- 116
- Issue
- 6
- Pages
- 647-655
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2012365932
- Cited by
- 126
- References
- 30
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 8 · 2012: 14
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- European Commission (MEST-CT-2005-020013)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- neuronal loss, neuronal cell death, Alzheimer's disease, frontal cortex, thalamus, amyloid plaques, tau hyperphosphorylation, stereology
- MeSH terms
- Age Factors, Alzheimer Disease, Analysis of Variance, Animals, Frontal Lobe, Humans, Immunohistochemistry, Mice, Transgenic, Nerve Degeneration, Neurons, Thalamus, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Paraffin Embedding, Cell Death, Extracellular Fluid, Mice, Presenilin-1, Gene Knock-In Techniques, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. https://app.cochat.ai/papers/10.1007/s00401-008-0451-6
- The paper
- Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M.-C., Wirths, O., & Bayer, T. A. (2008). Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathologica. https://doi.org/10.1007/s00401-008-0451-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.